SG11202005628RA - 4-azaindole compounds - Google Patents
4-azaindole compoundsInfo
- Publication number
- SG11202005628RA SG11202005628RA SG11202005628RA SG11202005628RA SG11202005628RA SG 11202005628R A SG11202005628R A SG 11202005628RA SG 11202005628R A SG11202005628R A SG 11202005628RA SG 11202005628R A SG11202005628R A SG 11202005628RA SG 11202005628R A SG11202005628R A SG 11202005628RA
- Authority
- SG
- Singapore
- Prior art keywords
- azaindole compounds
- azaindole
- compounds
- Prior art date
Links
- XWIYUCRMWCHYJR-UHFFFAOYSA-N 1h-pyrrolo[3,2-b]pyridine Chemical class C1=CC=C2NC=CC2=N1 XWIYUCRMWCHYJR-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762599875P | 2017-12-18 | 2017-12-18 | |
| PCT/US2018/065908 WO2019125977A1 (en) | 2017-12-18 | 2018-12-17 | 4-azaindole compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202005628RA true SG11202005628RA (en) | 2020-07-29 |
Family
ID=65003548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202005628RA SG11202005628RA (en) | 2017-12-18 | 2018-12-17 | 4-azaindole compounds |
Country Status (27)
| Country | Link |
|---|---|
| US (4) | US10544143B2 (en) |
| EP (1) | EP3728252B1 (en) |
| JP (1) | JP7289301B2 (en) |
| KR (1) | KR20200100709A (en) |
| CN (1) | CN111819176B (en) |
| AR (1) | AR113959A1 (en) |
| AU (1) | AU2018388464B2 (en) |
| BR (1) | BR112020011771A2 (en) |
| CA (1) | CA3085817A1 (en) |
| CL (1) | CL2020001546A1 (en) |
| DK (1) | DK3728252T3 (en) |
| EA (1) | EA202091484A1 (en) |
| ES (1) | ES2960411T3 (en) |
| FI (1) | FI3728252T3 (en) |
| HR (1) | HRP20231244T1 (en) |
| HU (1) | HUE064473T2 (en) |
| IL (1) | IL275344B2 (en) |
| LT (1) | LT3728252T (en) |
| MX (1) | MX2020006168A (en) |
| PE (1) | PE20210129A1 (en) |
| PL (1) | PL3728252T3 (en) |
| PT (1) | PT3728252T (en) |
| RS (1) | RS64728B1 (en) |
| SG (1) | SG11202005628RA (en) |
| SI (1) | SI3728252T1 (en) |
| TW (1) | TWI689510B (en) |
| WO (1) | WO2019125977A1 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10071079B2 (en) | 2016-06-29 | 2018-09-11 | Bristol-Myers Squibb Company | [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds |
| EA202091484A1 (en) * | 2017-12-18 | 2021-03-25 | Бристол-Маерс Сквибб Компани | 4-AZAINDOL CONNECTIONS |
| EP3728188B1 (en) * | 2017-12-20 | 2023-10-11 | Bristol-Myers Squibb Company | Aryl and heteroaryl substituted indole compounds |
| CN111511744B (en) * | 2017-12-20 | 2023-09-22 | 百时美施贵宝公司 | Diazaindole compounds |
| EP3728218B1 (en) * | 2017-12-20 | 2021-12-01 | Bristol-Myers Squibb Company | Amino indole compounds useful as tlr inhibitors |
| WO2019155042A1 (en) | 2018-02-12 | 2019-08-15 | F. Hoffmann-La Roche Ag | Novel sulfone compounds and derivatives for the treatment and prophylaxis of virus infection |
| CN112313228A (en) | 2018-06-12 | 2021-02-02 | 豪夫迈·罗氏有限公司 | Novel heteroaryl heterocyclyl compounds for the treatment of autoimmune diseases |
| WO2020020800A1 (en) | 2018-07-23 | 2020-01-30 | F. Hoffmann-La Roche Ag | Novel piperazine compounds for the treatment of autoimmune disease |
| JP7233809B2 (en) | 2018-09-04 | 2023-03-07 | エフ． ホフマン－ラ ロシュ アーゲー | Benzothiazole compounds for the treatment of autoimmune diseases |
| EP3847170B1 (en) | 2018-09-06 | 2022-06-22 | F. Hoffmann-La Roche AG | Novel cyclic amidine compounds for the treatment of autoimmune disease |
| US20240124489A1 (en) * | 2019-10-01 | 2024-04-18 | Bristol-Myers Squibb Company | Substituted bicyclic heteroaryl compounds |
| KR20220097434A (en) * | 2019-11-01 | 2022-07-07 | 브리스톨-마이어스 스큅 컴퍼니 | Substituted Pyrazole Compounds as Toll Receptor Inhibitors |
| CA3189816A1 (en) * | 2020-08-19 | 2022-02-24 | Chunjian Liu | Substituted heteroaryl compounds useful as inhibitors of tlr9 |
| CA3214808A1 (en) | 2021-04-16 | 2022-10-20 | Gilead Sciences, Inc. | Thienopyrrole compounds |
| CN114591339B (en) * | 2022-05-10 | 2022-08-02 | 上海维申医药有限公司 | Toll-like receptor inhibitor and preparation and application thereof |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0100348A3 (en) | 1997-10-20 | 2002-12-28 | Hoffmann La Roche | Bicycles containing a six menbered ring with one or two nitrogen atoms, process for their preparation, use of them, pharmaceutical compositions containing the same and intermediates |
| TR200102533T2 (en) | 1998-12-18 | 2006-06-21 | Axys Pharmaceuticals, Inc. | Protease inhibitors |
| EP1635846A4 (en) | 2003-06-20 | 2009-01-28 | Coley Pharm Gmbh | Small molecule toll-like receptor (tlr) antagonists |
| EP1756109B1 (en) | 2004-05-03 | 2016-07-13 | Janssen Pharmaceutica NV | Novel indole derivatives as selective androgen receptor modulators (sarms) |
| WO2006113458A1 (en) | 2005-04-15 | 2006-10-26 | Bristol-Myers Squibb Company | Heterocyclic inhibitors of protein arginine methyl transferases |
| JP2009532501A (en) | 2006-04-04 | 2009-09-10 | ミリアド ジェネティクス， インコーポレイテッド | Compounds for diseases and disorders |
| DE102006033109A1 (en) | 2006-07-18 | 2008-01-31 | Grünenthal GmbH | Substituted heteroaryl derivatives |
| US8027888B2 (en) | 2006-08-31 | 2011-09-27 | Experian Interactive Innovation Center, Llc | Online credit card prescreen systems and methods |
| US7977352B2 (en) | 2006-12-01 | 2011-07-12 | Galapagos Nv | Triazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases |
| GB0708141D0 (en) | 2007-04-26 | 2007-06-06 | Syngenta Participations Ag | Improvements in or relating to organic compounds |
| WO2008152471A1 (en) | 2007-06-12 | 2008-12-18 | Coley Pharmaceutical Group, Inc. | Quinazoline derivative useful as toll-like receptor antagonist |
| WO2009030996A1 (en) | 2007-09-05 | 2009-03-12 | Coley Pharmaceutical Group, Inc. | Triazole compounds as toll-like receptor (tlr) agonists |
| CL2009000904A1 (en) * | 2008-04-21 | 2010-04-30 | Shionogi & Co | Compounds derived from cyclohexyl sulfonamides having antagonist activity at the npy y5 receptor, pharmaceutical composition and pharmaceutical formulation comprising them. |
| BRPI0915231A2 (en) * | 2008-07-08 | 2018-06-12 | Intellikine Inc | kinase inhibitor compounds and methods of use |
| WO2010036905A1 (en) | 2008-09-26 | 2010-04-01 | Eisai R & D Management Co., Ltd. | Benzoxazole compounds and methods of use |
| US8785489B2 (en) | 2008-10-17 | 2014-07-22 | Boehringer Ingelheim International Gmbh | Heteroaryl substituted indole compounds useful as MMP-13 inhibitors |
| PT2364314E (en) * | 2008-12-09 | 2014-06-09 | Gilead Sciences Inc | Modulators of toll-like receptors |
| TWI462920B (en) | 2009-06-26 | 2014-12-01 | 葛萊伯格有限公司 | Novel compound useful for the treatment of degenerative and inflammatory diseases |
| US20110015219A1 (en) | 2009-07-16 | 2011-01-20 | Mallinckrodt Inc. | (+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof |
| WO2012054862A2 (en) | 2010-10-21 | 2012-04-26 | The Brigham And Women's Hospital, Inc. | Agents, compositions, and methods for treating pruritis and related skin conditions |
| AU2012205490B2 (en) | 2011-01-12 | 2017-02-02 | Array Biopharma, Inc. | Substituted benzoazepines as toll-like receptor modulators |
| WO2012097173A2 (en) | 2011-01-12 | 2012-07-19 | Ventirx Pharmaceuticals, Inc. | Substituted benzoazepines as toll-like receptor modulators |
| CA2837207A1 (en) | 2011-06-01 | 2012-12-06 | Janus Biotherapeutics, Inc. | Novel immune system modulators |
| WO2012167046A1 (en) | 2011-06-01 | 2012-12-06 | Janus Biotherapeutics, Inc. | Novel immune system modulators |
| ES2602813T3 (en) | 2011-06-09 | 2017-02-22 | Rhizen Pharmaceuticals S.A. | New compounds as modulators of GPR-119 |
| EP2731948B1 (en) | 2011-07-15 | 2015-09-09 | Janssen Pharmaceuticals, Inc. | Novel substituted indole derivatives as gamma secretase modulators |
| JP2013075834A (en) * | 2011-09-29 | 2013-04-25 | Kowa Co | Pyrazolopyrimidine-7-amine derivative exhibiting tlr9-inhibiting activity |
| AU2012318694B2 (en) | 2011-10-04 | 2016-12-22 | Janus Biotherapeutics, Inc. | Novel imidazole quinoline-based immune system modulators |
| TWI619704B (en) | 2012-05-18 | 2018-04-01 | 大日本住友製藥股份有限公司 | Carboxylic acid compounds |
| JO3407B1 (en) * | 2012-05-31 | 2019-10-20 | Eisai R&D Man Co Ltd | Tetrahydropyrazolopyrimidine Compounds |
| EP2738172A1 (en) * | 2012-11-28 | 2014-06-04 | Almirall, S.A. | New bicyclic compounds as crac channel modulators |
| SI3057964T1 (en) | 2013-10-14 | 2020-03-31 | Eisai R&D Management Co., Ltd. | Selectively substituted quinoline compounds |
| EP3080124A1 (en) | 2013-12-13 | 2016-10-19 | Takeda Pharmaceutical Company Limited | Pyrrolo[3,2-c]pyridine derivatives as tlr inhibitors |
| CN110938076B (en) | 2014-08-15 | 2021-08-10 | 正大天晴药业集团股份有限公司 | Pyrrolopyrimidines as TLR7 agonists |
| EP3183251A4 (en) | 2014-08-22 | 2017-12-27 | Janus Biotherapeutics, Inc. | Novel n2, n4, n7, 6-tetrasubstituted pteridine-2,4,7-triamine and 2, 4, 6, 7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof |
| AR103232A1 (en) * | 2014-12-22 | 2017-04-26 | Bristol Myers Squibb Co | TGFbR ANTAGONISTS |
| CA3031675A1 (en) | 2016-07-30 | 2018-02-08 | Bristol-Myers Squibb Company | Dimethoxyphenyl substituted indole compounds as tlr7, tlr8 or tlr9 inhibitors |
| CN109923108B (en) * | 2016-09-09 | 2022-04-29 | 百时美施贵宝公司 | Pyridyl-substituted indole compounds |
| EA202091484A1 (en) * | 2017-12-18 | 2021-03-25 | Бристол-Маерс Сквибб Компани | 4-AZAINDOL CONNECTIONS |
-
2018
- 2018-12-17 EA EA202091484A patent/EA202091484A1/en unknown
- 2018-12-17 WO PCT/US2018/065908 patent/WO2019125977A1/en active Application Filing
- 2018-12-17 TW TW107145397A patent/TWI689510B/en active
- 2018-12-17 JP JP2020533676A patent/JP7289301B2/en active Active
- 2018-12-17 MX MX2020006168A patent/MX2020006168A/en unknown
- 2018-12-17 AR ARP180103685A patent/AR113959A1/en unknown
- 2018-12-17 US US16/222,145 patent/US10544143B2/en active Active
- 2018-12-17 PT PT188306484T patent/PT3728252T/en unknown
- 2018-12-17 EP EP18830648.4A patent/EP3728252B1/en active Active
- 2018-12-17 CA CA3085817A patent/CA3085817A1/en active Pending
- 2018-12-17 ES ES18830648T patent/ES2960411T3/en active Active
- 2018-12-17 SG SG11202005628RA patent/SG11202005628RA/en unknown
- 2018-12-17 DK DK18830648.4T patent/DK3728252T3/en active
- 2018-12-17 KR KR1020207020519A patent/KR20200100709A/en not_active Application Discontinuation
- 2018-12-17 HU HUE18830648A patent/HUE064473T2/en unknown
- 2018-12-17 RS RS20230961A patent/RS64728B1/en unknown
- 2018-12-17 CN CN201880080921.XA patent/CN111819176B/en active Active
- 2018-12-17 PE PE2020000741A patent/PE20210129A1/en unknown
- 2018-12-17 AU AU2018388464A patent/AU2018388464B2/en active Active
- 2018-12-17 SI SI201830990T patent/SI3728252T1/en unknown
- 2018-12-17 HR HRP20231244TT patent/HRP20231244T1/en unknown
- 2018-12-17 BR BR112020011771-4A patent/BR112020011771A2/en unknown
- 2018-12-17 FI FIEP18830648.4T patent/FI3728252T3/en active
- 2018-12-17 PL PL18830648.4T patent/PL3728252T3/en unknown
- 2018-12-17 LT LTEPPCT/US2018/065908T patent/LT3728252T/en unknown
-
2019
- 2019-11-26 US US16/695,303 patent/US10730877B2/en active Active
-
2020
- 2020-06-10 CL CL2020001546A patent/CL2020001546A1/en unknown
- 2020-06-14 IL IL275344A patent/IL275344B2/en unknown
- 2020-06-24 US US16/910,101 patent/US11053244B1/en active Active
-
2021
- 2021-04-30 US US17/245,595 patent/US11820768B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL275365A (en) | 6-azaindole compounds | |
| IL275344A (en) | 4-azaindole compounds | |
| GB201708456D0 (en) | Senolytic compounds | |
| GB201704327D0 (en) | Compounds | |
| GB201700814D0 (en) | Compounds | |
| GB201704325D0 (en) | Compounds | |
| GB201715342D0 (en) | Compounds | |
| GB201713962D0 (en) | Compounds | |
| GB201707938D0 (en) | Compounds | |
| GB201706162D0 (en) | Compounds | |
| GB201715786D0 (en) | Compounds | |
| GB201707856D0 (en) | Compounds | |
| GB201702221D0 (en) | Compounds | |
| GB201716369D0 (en) | Compounds | |
| GB201707852D0 (en) | Compounds | |
| GB201703282D0 (en) | Compounds | |
| GB201716392D0 (en) | Compounds | |
| GB201716352D0 (en) | Compounds | |
| GB201716374D0 (en) | Compounds | |
| GB201713319D0 (en) | Compounds | |
| GB201713318D0 (en) | Compounds | |
| GB201711982D0 (en) | Compounds | |
| GB201709642D0 (en) | Compounds | |
| GB201708846D0 (en) | Compounds | |
| GB201708848D0 (en) | Compounds |